Executive Series: Anatara Lifesciences (ANR) Chairman & CEO, Dr Mel Bridges


In this short video we discuss the current negotiations with #1 global animal health company, Zoetis, regarding a commercial agreement for the worldwide development, distribution and marketing of ANR’s Detach product, in addition to the submission of the Company’s dossier to the Australian Pesticides and Veterinary Medicines Authority (APVMA), seeking regulatory approval to register Detach for commercial marketing in Australia.


CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...

Anatara Lifesciences ASX:ANR


Please sign in to comment on this wire.